Periostin is a new potential prognostic biomarker for glioma

Tumor Biology

Volumn 35, Issue 6, 2014, Pages 5877-5883

  Tian, Buxian ^a   Zhang, Yuhong ^b   Zhang, Jing ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

^b Jinzhou Central Hospital   (China)

Author keywords

Gliomas; Immunohistochemistry; Periostin; Prognosis; Stem cell

Indexed keywords

CD133 ANTIGEN; KI 67 ANTIGEN; MESSENGER RNA; TRANSCRIPTION FACTOR RUNX2;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STEM CELL; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; FEMALE; FLOW CYTOMETRY; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARNOFSKY PERFORMANCE STATUS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, NEOPLASM; BRAIN NEOPLASMS; CELL ADHESION MOLECULES; FEMALE; GLIOMA; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PEPTIDES; PROGNOSIS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84904733505     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1778-3     Document Type: Article

References (23)

1. Ulukaya E, Frame FM, Cevatemre B, Pellacani D, Walker H, Mann VM, et al. Differential cytotoxic activity of a novel palladium-based compound on prostate cell lines, primary prostate epithelial cells and prostate stem cells. PLoS One. 2013;8(5):e64278.
2. Ren F, ShengWQ, Du X. CD133: a cancer stem cells marker, is used in colorectal cancers. World J Gastroenterol. 2013;19(17):2603-11.
3. Shekhani MT, Jayanthy AS, Maddodi N, Setaluri V. Cancer stem cells and tumor transdifferentiation: implications for novel therapeutic strategies. Am J Stem Cells. 2013;2(1):52-61.
4. Liao WY, Liaw CC, Huang YC, Han HY, Hsu HW, Hwang SM, et al. Cyclohexylmethyl flavonoids suppress propagation of breast cancer stem cells via downregulation of NANOG. Evid Based Complement Alternat Med. 2013;2013:170261.
5. Chen SF, Lin YS, Jao SW, Chang YC, Liu CL, Lin YJ, et al. Pulmonary adenocarcinoma in malignant pleural effusion enriches cancer stem cell properties during metastatic cascade. PLoS One. 2013;8(5):e54659.
6. NakadaM, Nambu E, Furuyama N, Yoshida Y, Takino T, Hayashi Y, et al. Integrin α3 is overexpressed in glioma stem-like cells and promotes invasion. Br J Cancer. 2013;108(12):2516-24.
7. Tu SM. Cancer: a "stem-cell" disease? Cancer Cell Int. 2013;13(1):40.
8. Wei Y, Jiang Y, Zou F, Liu Y, Wang S, Xu N, et al. Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells. Proc Natl Acad Sci U S A. 2013;110(17):6829-34.
9. Jin X, Jin X, Jung JE, Beck S, Kim H. Cell surface Nestin is a biomarker for glioma stem cells. Biochem Biophys Res Commun. 2013;433(4):496-501.
10. Dahlrot RH, Hermansen SK, Hansen S, Kristensen BW. What is the clinical value of cancer stem cell markers in gliomas? Int J Clin Exp Pathol. 2013;6(3):334-48.
11. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003;63(18):5821-8. (Pubitemid 37187480)
12. Liu CG, Lu Y, Wang BB, Zhang YJ, Zhang RS, Lu Y, et al. Clinical implications of stem cell gene Oct-4 expression in breast cancer. Ann Surg. 2011;253(6):1165-71.
13. Malanchi I, Santamaria-Martínez A, Susanto E, Peng H, Lehr HA, Delaloye JF, et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature. 2011;481(7379):85.
14. Kyutoku M, Taniyama Y, Katsuragi N, Shimizu H, Kunugiza Y, Iekushi K, et al. Role of periostin in cancer progression and metastasis: inhibition of breast cancer progression and metastasis by antiperiostin antibody in a murine model. Int J Mol Med. 2011;28(2):181-6.
15. Xu D, Xu H, Ren Y, Liu C, Wang X, Zhang H, et al. Cancer stem cell-related gene periostin: a novel prognostic marker for breast cancer. PLoS One. 2012;7(10):e46670.
16. Listernick R, Charrow J, Greenwald M, Mets M. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr. 1994;125(1):63-6. (Pubitemid 24225179)
17. Caruso C, Carcaterra M, Donato V. Role of radiotherapy for high grade gliomas management. J Neurosurg Sci. 2013;57(2):163-9.
18. Ahmed AU, Auffinger B, Lesniak MS. Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategies. Expert Rev Neurother. 2013;13(5):545-55.
19. Rath P, Lal B, Ajala O, Li Y, Xia S, Kim J, et al. In vivo c-Met pathway inhibition depletes human glioma xenografts of tumor-propagating stem-like cells. Transl Oncol. 2013;6(2):104-11.
20. LehnusKS, Donovan LK, HuangX, Zhao N, Warr TJ, Pilkington GJ, et al. CD133 glycosylation is enhanced by hypoxia in cultured glioma stem cells. Int J Oncol. 2013;42(3):1011-7.
21. Liu X, Chen L, Jiang Z, Wang J, Su Z, Li G, et al. Malignant behavioral characteristics of CD133(+/-) glioblastoma cells from a Northern Chinese population. Exp Ther Med. 2013;5(1):65-72.
22. Pallini R, Ricci-Vitiani L, Banna GL, Signore M, Lombardi D, Todaro M, et al. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res. 2008;14(24):8205-12.
23. Wang H, Wang Y, Jiang C. Stromal protein periostin identified as a progression associated and prognostic biomarker in glioma via inducing an invasive and proliferative phenotype. Int J Oncol. 2013;42(5):1716-24.